IMMUNOHISTOCHEMISTRY AFP ALPHA FETO PROTEIN Test
Components: AFP Alpha Fetoprotein
Price: 410.0 AED
Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery: Sample Daily by 6 pm; Report Block: 5 days, Tissue Biopsy: 5 days, Tissue large complex: 7 days
Method: Immunohistochemistry
Test type: Cancer
Doctor: Oncologist, Pathologist
Test Department:
Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details
The immunohistochemistry AFP (Alpha Fetoprotein) test is a diagnostic tool used to detect the presence of AFP in tissue samples. AFP is a protein that is normally produced by the liver and yolk sac of a developing fetus during pregnancy. However, elevated levels of AFP in adults can indicate the presence of certain types of cancer, particularly liver cancer.
During the test, a tissue sample, usually obtained through a biopsy or surgical procedure, is treated with specific antibodies that bind to AFP if it is present. These antibodies are labeled with a marker, such as an enzyme or fluorescent dye, which allows the visualization of the AFP in the tissue sample. The presence of AFP can then be observed under a microscope or through other imaging techniques.
The immunohistochemistry AFP test is commonly used in the diagnosis and monitoring of liver cancer. It can help determine the extent of the disease, guide treatment decisions, and assess the effectiveness of therapy. The test is also useful in distinguishing between different types of liver tumors, as AFP levels can vary depending on the specific tumor type.
Overall, the immunohistochemistry AFP test is a valuable tool in the diagnosis and management of liver cancer and other conditions associated with elevated AFP levels. It provides important information to healthcare professionals, aiding in the development of an appropriate treatment plan for the patient.
Test Name | IMMUNOHISTOCHEMISTRY AFP ALPHA FETO PROTEIN Test |
---|---|
Components | |
Price | 410.0 AED |
Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
Report Delivery | Sample Daily by 6 pm; Report Block : 5 days Tissue Biopsy : 5 days Tissue large complex : 7 days |
Method | Immunohistochemistry |
Test type | Cancer |
Doctor | Oncologist, Pathologist |
Test Department: | |
Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
Test Details | The immunohistochemistry AFP (Alpha Fetoprotein) test is a diagnostic tool used to detect the presence of AFP in tissue samples. AFP is a protein that is normally produced by the liver and yolk sac of a developing fetus during pregnancy. However, elevated levels of AFP in adults can indicate the presence of certain types of cancer, particularly liver cancer. During the test, a tissue sample, usually obtained through a biopsy or surgical procedure, is treated with specific antibodies that bind to AFP if it is present. These antibodies are labeled with a marker, such as an enzyme or fluorescent dye, which allows the visualization of the AFP in the tissue sample. The presence of AFP can then be observed under a microscope or through other imaging techniques. The immunohistochemistry AFP test is commonly used in the diagnosis and monitoring of liver cancer. It can help determine the extent of the disease, guide treatment decisions, and assess the effectiveness of therapy. The test is also useful in distinguishing between different types of liver tumors, as AFP levels can vary depending on the specific tumor type. Overall, the immunohistochemistry AFP test is a valuable tool in the diagnosis and management of liver cancer and other conditions associated with elevated AFP levels. It provides important information to healthcare professionals, aiding in the development of an appropriate treatment plan for the patient. |